Replies to post #361532 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Very obliging of the UK and European regulators, who saw fit to accept the new endpoints.
And they apparently see no reason why they should not be prepared to accept the data analysed in such a way.

All they ever accepted was that the change would not harm patients.

The EMA was not even a party to those actions.